Roundtable on Black in cancer research and oncology

Saying hello and good morning, afternoon, evening, wherever everyone is joining from. My name is Kathryn Mcginnis. I'm an editor at the Cancer Team in Nature Communications and myself and my colleague, Lisa, who is joining from Nature Cancer. And we're delighted to welcome you to this Roundtable Discussion on Black and CANCER RESEARCH and Oncology.

What we're really hoping for today is to have a fruitful and thought-provoking Discussion with our very eminent speakers and also to welcome questions and comments from you as our audience. We're very aware that our audience is partly editorial staff from Springer Nature and also people from further afield.

So just some very quick housekeeping to start. This meeting is being recorded and it will be made available to all participants after the session. You will be able to submit questions during the talk using the chat function which should be on screen. And we've also prepared some questions that have come from the cancer community already within Springer Nature.

But first of all, we'd like to start introducing you to our speakers for this session. So without further ado, I'd like to introduce our first speaker who is Dr. Brandon Blu. So Brandon is an oncologist at the Moffit Cancer Centre and is very kindly joining us from there and he's working to increase inclusion within clinical research.

So, Brandon, if it's all right, I'll hand over to you. Thank you so much. I'm so happy to be here. I appreciate everyone for this time period and I am going to share my screen so I can talk to everyone about kind of what I do in sunny Tampa Florida here in the United States and how we can hopefully have a very wonderful conversation today. Eight, we go, all right, perfect. So hopefully, folks are seeing my screen and we are able to get started. So, you know, I am a doctor who basically sees Blood and bone marrow cancers.